APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Digital Pathology AI-Assisted Diagnostic System

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Digital Pathology AI-Assisted Diagnostic System Market Analysis and Forecast 2026-2032

Report ID 174117920215 January 2026195 pages

Choose your research edition.

Industry ResearchDigital Pathology AI-Assisted Diagnostic System Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Digital Pathology AI-Assisted Diagnostic System Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Digital Pathology AI-Assisted Diagnostic System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Digital Pathology AI-Assisted Diagnostic System Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Digital Pathology AI-Assisted Diagnostic System Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Digital Pathology AI-Assisted Diagnostic System market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital Pathology AI-Assisted Diagnostic System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital Pathology AI-Assisted Diagnostic System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital Pathology AI-Assisted Diagnostic System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital Pathology AI-Assisted Diagnostic System is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital Pathology AI-Assisted Diagnostic System include Lunit, VUNO, Inc., Konfoong Bioinformation Tech, Techcyte, Hologic, Canon Medical, ANNALISE-AI PTY LTD, CellsVision and Dipath, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital Pathology AI-Assisted Diagnostic System, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital Pathology AI-Assisted Diagnostic System, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital Pathology AI-Assisted Diagnostic System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital Pathology AI-Assisted Diagnostic System revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital Pathology AI-Assisted Diagnostic System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital Pathology AI-Assisted Diagnostic System revenue, projected growth trends, production technology, application and end-user industry.

Digital Pathology AI-Assisted Diagnostic System Segment by Company

Lunit

VUNO, Inc.

Konfoong Bioinformation Tech

Techcyte

Hologic

Canon Medical

ANNALISE-AI PTY LTD

CellsVision

Dipath

Cytowiz Incorporated

Wuhan Zhongji Biotech

Digital Pathology AI-Assisted Diagnostic System Segment by Type

Equipment

Software

Digital Pathology AI-Assisted Diagnostic System Segment by Application

Cervix

Breast

Gastrointestinal

Other

Digital Pathology AI-Assisted Diagnostic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Pathology AI-Assisted Diagnostic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Pathology AI-Assisted Diagnostic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Pathology AI-Assisted Diagnostic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital Pathology AI-Assisted Diagnostic System in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital Pathology AI-Assisted Diagnostic System company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pathology AI-Assisted Diagnostic System revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital Pathology AI-Assisted Diagnostic System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equipment Major Player Table 3. Software Major Player Table 4. Global Digital Pathology AI-Assisted Diagnostic System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cervix Major Player Table 6. Breast Major Player Table 7. Gastrointestinal Major Player Table 8. Other Major Player Table 9. Digital Pathology AI-Assisted Diagnostic System Industry Trends Table 10. Digital Pathology AI-Assisted Diagnostic System Industry Drivers Table 11. Digital Pathology AI-Assisted Diagnostic System Industry Opportunities and Challenges Table 12. Digital Pathology AI-Assisted Diagnostic System Industry Restraints Table 13. Global Digital Pathology AI-Assisted Diagnostic System Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Digital Pathology AI-Assisted Diagnostic System Market Share by Region (2021-2026) Table 16. Global Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Digital Pathology AI-Assisted Diagnostic System Market Share by Region (2027-2032) Table 18. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Players (2021-2026) Table 20. Global Digital Pathology AI-Assisted Diagnostic System Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Digital Pathology AI-Assisted Diagnostic System Key Players Headquarters & Area Served Table 22. Global Digital Pathology AI-Assisted Diagnostic System Players, Product Type & Application Table 23. Global Digital Pathology AI-Assisted Diagnostic System Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Digital Pathology AI-Assisted Diagnostic System by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Type (2021-2026) Table 30. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Type (2027-2032) Table 31. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Application (2021-2026) Table 35. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Application (2027-2032) Table 36. Lunit Company Information Table 37. Lunit Business Overview Table 38. Lunit Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Lunit Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 40. Lunit Recent Development Table 41. VUNO, Inc. Company Information Table 42. VUNO, Inc. Business Overview Table 43. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 45. VUNO, Inc. Recent Development Table 46. Konfoong Bioinformation Tech Company Information Table 47. Konfoong Bioinformation Tech Business Overview Table 48. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 50. Konfoong Bioinformation Tech Recent Development Table 51. Techcyte Company Information Table 52. Techcyte Business Overview Table 53. Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Techcyte Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 55. Techcyte Recent Development Table 56. Hologic Company Information Table 57. Hologic Business Overview Table 58. Hologic Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Hologic Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 60. Hologic Recent Development Table 61. Canon Medical Company Information Table 62. Canon Medical Business Overview Table 63. Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Canon Medical Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 65. Canon Medical Recent Development Table 66. ANNALISE-AI PTY LTD Company Information Table 67. ANNALISE-AI PTY LTD Business Overview Table 68. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 70. ANNALISE-AI PTY LTD Recent Development Table 71. CellsVision Company Information Table 72. CellsVision Business Overview Table 73. CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. CellsVision Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 75. CellsVision Recent Development Table 76. Dipath Company Information Table 77. Dipath Business Overview Table 78. Dipath Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Dipath Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 80. Dipath Recent Development Table 81. Cytowiz Incorporated Company Information Table 82. Cytowiz Incorporated Business Overview Table 83. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 85. Cytowiz Incorporated Recent Development Table 86. Wuhan Zhongji Biotech Company Information Table 87. Wuhan Zhongji Biotech Business Overview Table 88. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product Portfolio Table 90. Wuhan Zhongji Biotech Recent Development Table 91. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (US$ Million) & (2027-2032) Table 105. China Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 106. China Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 107. China Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 108. China Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Digital Pathology AI-Assisted Diagnostic System Image Figure 2. Global Digital Pathology AI-Assisted Diagnostic System Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital Pathology AI-Assisted Diagnostic System Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equipment Image Figure 5. Software Image Figure 6. Global Digital Pathology AI-Assisted Diagnostic System Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Digital Pathology AI-Assisted Diagnostic System Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cervix Image Figure 9. Breast Image Figure 10. Gastrointestinal Image Figure 11. Other Image Figure 12. Global Digital Pathology AI-Assisted Diagnostic System Market Size (US$ Million) & (2021-2032) Figure 13. Global Digital Pathology AI-Assisted Diagnostic System Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Digital Pathology AI-Assisted Diagnostic System Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Digital Pathology AI-Assisted Diagnostic System Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Type (2021-2032) Figure 20. Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Application (2021-2032) Figure 23. North America Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032) Figure 25. North America Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032) Figure 26. North America Digital Pathology AI-Assisted Diagnostic System Revenue Share by Country (2021-2032) Figure 27. United States Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032) Figure 32. Europe Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032) Figure 33. Europe Digital Pathology AI-Assisted Diagnostic System Revenue Share by Country (2021-2032) Figure 34. Germany Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032) Figure 44. China Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032) Figure 45. Asia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032) Figure 47. Asia Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032) Figure 48. Asia Digital Pathology AI-Assisted Diagnostic System Revenue Share by Region (2021-2032) Figure 49. Japan Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032) Figure 57. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032) Figure 58. SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue Share by Country (2021-2032) Figure 59. Brazil Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Digital Pathology AI-Assisted Diagnostic System Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Software
Applications
  • Cervix
  • Breast
  • Gastrointestinal
  • Other
Companies covered
  • Lunit
  • VUNO, Inc.
  • Konfoong Bioinformation Tech
  • Techcyte
  • Hologic
  • Canon Medical
  • ANNALISE-AI PTY LTD
  • CellsVision
  • Dipath
  • Cytowiz Incorporated
  • Wuhan Zhongji Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital Pathology AI-Assisted Diagnostic System Market by Type
  3. 1.2.1 Global Digital Pathology AI-Assisted Diagnostic System Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equipment
  5. 1.2.3 Software
  6. 1.3 Digital Pathology AI-Assisted Diagnostic System Market by Application
  7. 1.3.1 Global Digital Pathology AI-Assisted Diagnostic System Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cervix
  9. 1.3.3 Breast
  10. 1.3.4 Gastrointestinal
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Digital Pathology AI-Assisted Diagnostic System Market Dynamics
  1. 2.1 Digital Pathology AI-Assisted Diagnostic System Industry Trends
  2. 2.2 Digital Pathology AI-Assisted Diagnostic System Industry Drivers
  3. 2.3 Digital Pathology AI-Assisted Diagnostic System Industry Opportunities and Challenges
  4. 2.4 Digital Pathology AI-Assisted Diagnostic System Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital Pathology AI-Assisted Diagnostic System Market Perspective (2021-2032)
  2. 3.2 Global Digital Pathology AI-Assisted Diagnostic System Growth Trends by Region
  3. 3.2.1 Global Digital Pathology AI-Assisted Diagnostic System Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital Pathology AI-Assisted Diagnostic System Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Players
  2. 4.1.1 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital Pathology AI-Assisted Diagnostic System Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital Pathology AI-Assisted Diagnostic System Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital Pathology AI-Assisted Diagnostic System Key Players Headquarters & Area Served
  7. 4.4 Global Digital Pathology AI-Assisted Diagnostic System Players, Product Type & Application
  8. 4.5 Global Digital Pathology AI-Assisted Diagnostic System Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital Pathology AI-Assisted Diagnostic System Market CR5 and HHI
  11. 4.6.3 2025 Digital Pathology AI-Assisted Diagnostic System Tier 1, Tier 2, and Tier 3
5 Digital Pathology AI-Assisted Diagnostic System Market Size by Type
  1. 5.1 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 5.3 Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Type (2021-2032)
6 Digital Pathology AI-Assisted Diagnostic System Market Size by Application
  1. 6.1 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  3. 6.3 Global Digital Pathology AI-Assisted Diagnostic System Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lunit
  2. 7.1.1 Lunit Company Information
  3. 7.1.2 Lunit Business Overview
  4. 7.1.3 Lunit Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lunit Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  6. 7.1.5 Lunit Recent Developments
  7. 7.2 VUNO, Inc.
  8. 7.2.1 VUNO, Inc. Company Information
  9. 7.2.2 VUNO, Inc. Business Overview
  10. 7.2.3 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  11. 7.2.4 VUNO, Inc. Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  12. 7.2.5 VUNO, Inc. Recent Developments
  13. 7.3 Konfoong Bioinformation Tech
  14. 7.3.1 Konfoong Bioinformation Tech Company Information
  15. 7.3.2 Konfoong Bioinformation Tech Business Overview
  16. 7.3.3 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Konfoong Bioinformation Tech Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  18. 7.3.5 Konfoong Bioinformation Tech Recent Developments
  19. 7.4 Techcyte
  20. 7.4.1 Techcyte Company Information
  21. 7.4.2 Techcyte Business Overview
  22. 7.4.3 Techcyte Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Techcyte Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  24. 7.4.5 Techcyte Recent Developments
  25. 7.5 Hologic
  26. 7.5.1 Hologic Company Information
  27. 7.5.2 Hologic Business Overview
  28. 7.5.3 Hologic Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Hologic Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  30. 7.5.5 Hologic Recent Developments
  31. 7.6 Canon Medical
  32. 7.6.1 Canon Medical Company Information
  33. 7.6.2 Canon Medical Business Overview
  34. 7.6.3 Canon Medical Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Canon Medical Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  36. 7.6.5 Canon Medical Recent Developments
  37. 7.7 ANNALISE-AI PTY LTD
  38. 7.7.1 ANNALISE-AI PTY LTD Company Information
  39. 7.7.2 ANNALISE-AI PTY LTD Business Overview
  40. 7.7.3 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ANNALISE-AI PTY LTD Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  42. 7.7.5 ANNALISE-AI PTY LTD Recent Developments
  43. 7.8 CellsVision
  44. 7.8.1 CellsVision Company Information
  45. 7.8.2 CellsVision Business Overview
  46. 7.8.3 CellsVision Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  47. 7.8.4 CellsVision Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  48. 7.8.5 CellsVision Recent Developments
  49. 7.9 Dipath
  50. 7.9.1 Dipath Company Information
  51. 7.9.2 Dipath Business Overview
  52. 7.9.3 Dipath Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Dipath Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  54. 7.9.5 Dipath Recent Developments
  55. 7.10 Cytowiz Incorporated
  56. 7.10.1 Cytowiz Incorporated Company Information
  57. 7.10.2 Cytowiz Incorporated Business Overview
  58. 7.10.3 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Cytowiz Incorporated Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  60. 7.10.5 Cytowiz Incorporated Recent Developments
  61. 7.11 Wuhan Zhongji Biotech
  62. 7.11.1 Wuhan Zhongji Biotech Company Information
  63. 7.11.2 Wuhan Zhongji Biotech Business Overview
  64. 7.11.3 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Wuhan Zhongji Biotech Digital Pathology AI-Assisted Diagnostic System Product Portfolio
  66. 7.11.5 Wuhan Zhongji Biotech Recent Developments
8 North America
  1. 8.1 North America Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
  2. 8.2 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032)
  5. 8.3 North America Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032)
  9. 8.5 North America Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country
  11. 8.6.1 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
  2. 9.2 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032)
  5. 9.3 Europe Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032)
  9. 9.5 Europe Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country
  11. 9.6.1 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
  2. 10.2 China Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 10.2.1 China Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026)
  4. 10.2.2 China Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032)
  5. 10.3 China Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032)
  6. 10.4 China Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  7. 10.4.1 China Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026)
  8. 10.4.2 China Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032)
  9. 10.5 China Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
  2. 11.2 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032)
  5. 11.3 Asia Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032)
  9. 11.5 Asia Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Country
  11. 11.6.1 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue (2021-2032)
  2. 12.2 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country
  11. 12.6.1 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital Pathology AI-Assisted Diagnostic System Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst